These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 11527137)

  • 1. Influence of multiple risk factors on the hazard of hypertension.
    Kannel WB
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S53-7. PubMed ID: 11527137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An integrated view of hypertension.
    Kannel WB
    J Hum Hypertens; 1989 Dec; 3 Suppl 2():3-8. PubMed ID: 2607526
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of vascular risk factors in the hypertensive patient.
    Taylor SH
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():10-6. PubMed ID: 2148191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is left ventricular hypertrophy in hypertension a marker for coronary risk factors?].
    Otterstad JE
    Tidsskr Nor Laegeforen; 1993 Feb; 113(5):609-13. PubMed ID: 8465321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inter-relationships between hypertension, left ventricular hypertrophy and coronary heart disease.
    Devereux RB; Roman MJ
    J Hypertens Suppl; 1993 Jun; 11(4):S3-9. PubMed ID: 8377033
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From left ventricular hypertrophy to congestive heart failure: management of hypertensive heart disease.
    Gradman AH; Alfayoumi F
    Prog Cardiovasc Dis; 2006; 48(5):326-41. PubMed ID: 16627048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular risk as defined in the 2003 European blood pressure classification: the assessment of an additional predictive value of pulse pressure on mortality.
    Thomas F; Blacher J; Benetos A; Safar ME; Pannier B
    J Hypertens; 2008 Jun; 26(6):1072-7. PubMed ID: 18475143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stroke and coronary heart disease in treated hypertension -- a prospective cohort study over three decades.
    Almgren T; Persson B; Wilhelmsen L; Rosengren A; Andersson OK
    J Intern Med; 2005 Jun; 257(6):496-502. PubMed ID: 15910553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relation of electrocardiographic left ventricular hypertrophy to blood pressure, body mass index, serum lipids and blood sugar levels in adult Nigerians.
    Opadijo OG; Omotoso AB; Akande AA
    Afr J Med Med Sci; 2003 Dec; 32(4):395-9. PubMed ID: 15259925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation between white blood cell count and several risk factors for coronary heart disease in patients with systemic hypertension.
    Capuano V; Lamaida N; Mazzotta G; Scotto di Quacquaro G
    G Ital Cardiol; 1998 May; 28(5):530-5. PubMed ID: 9646068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study.
    de Simone G; Olsen MH; Wachtell K; Hille DA; Dahlöf B; Ibsen H; Kjeldsen SE; Lyle PA; Devereux RB
    J Hum Hypertens; 2007 Aug; 21(8):625-32. PubMed ID: 17476291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concept and usefulness of cardiovascular risk profiles.
    Kannel WB; D'Agostino RB; Sullivan L; Wilson PW
    Am Heart J; 2004 Jul; 148(1):16-26. PubMed ID: 15215787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
    Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
    Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Arrhythmia risk and noninvasive markers in hypertensive left ventricular hypertrophy].
    Akdeniz B; Güneri S; Badak O; Aslan O; Tamci B
    Anadolu Kardiyol Derg; 2002 Jun; 2(2):121-9; AXVII. PubMed ID: 12134537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cardiovascular risk stratification. Systolic, diastolic or pulse pressure?].
    Pede S; Lombardo M
    Ital Heart J Suppl; 2001 Apr; 2(4):356-8. PubMed ID: 19397006
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of myocardial diastolic dysfunction on coronary flow reserve in hypertensive patients with left ventricular hypertrophy.
    Galderisi M; Cicala S; De Simone L; Caso P; Petrocelli A; Pietropaolo L; Celentano A; Mininni N; de Divitiis O
    Ital Heart J; 2001 Sep; 2(9):677-84. PubMed ID: 11666096
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of prolonged ventricular repolarization in hypertension.
    Schillaci G; Pirro M; Ronti T; Gemelli F; Pucci G; Innocente S; Porcellati C; Mannarino E
    Arch Intern Med; 2006 Apr; 166(8):909-13. PubMed ID: 16636218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hypertension and heart disease].
    Gerdts E; Omvik P; Mo R; Kjeldsen SE
    Tidsskr Nor Laegeforen; 2004 Mar; 124(6):802-5. PubMed ID: 15039815
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.